Search

alt
0500

FiltersClear filters

Status
Sex
Age

Pfizer clinical trials

Search Results

We found 149 clinical trials for: 1000 miles

Recruiting
A Study to Learn About the Effects of the Combination of Elranatamab (PF-06863135) and Iberdomide in Patients With Relapsed or Refractory Multiple Myeloma (MagnetisMM-30)
  • Recruiting
NCT06215118
Sex: All
Age: 18+
Locations: 35
View study
Recruiting
Efficacy and Safety Study of Rimegepant for the Preventative Treatment of Migraine in Pediatric Subjects
  • Recruiting
NCT05156398
Sex: All
Age: 6 - 17
Locations: 50
View study
Recruiting
A Study to Learn How PF-06821497 (Mevrometostat) Works in Men With Metastatic Castration-resistant Prostate Cancer.
  • Recruiting
NCT06629779
Sex: Male
Age: 18+
Locations: 128
View study
Recruiting
A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue
  • Recruiting
NCT06989437
Sex: All
Age: 18+
Locations: 9
View study
Recruiting
A Study to Learn About the Study Medicine Aztreonam-Avibactam (ATM-AVI) in Infants and Newborns Admitted in Hospitals With Bacterial Infection (CHERISH)
  • Recruiting
NCT06462235
Sex: All
Age: Up to 39 weeks
Locations: 23
View study
Recruiting
Study With Elranatamab Versus Lenalidomide in Patients With Newly Diagnosed Multiple Myeloma After Transplant
  • Recruiting
NCT05317416
Sex: All
Age: 18+
Locations: 222
View study
Recruiting
A Study to Learn About the Study Medicine Ibuzatrelvir in Adults With COVID-19 Who Are Severely Immunocompromised
  • Recruiting
NCT07013474
Sex: All
Age: 18+
Locations: 50
View study
Recruiting
A Study to Learn About the Investigational Medicine Called PF-06821497 (Mevrometostat) in Men With mCRPC Who Were Previously Treated With Abiraterone Acetate for Prostate Cancer (MEVPRO-1).
  • Recruiting
NCT06551324
Sex: Male
Age: 18+
Locations: 50
View study
Recruiting
A Study to Understand How the Study Medicine (PF-06823859) Works in People With Active Idiopathic Inflammatory Myopathies [Dermatomyositis (DM) and Polymyositis (PM)]
  • Recruiting
NCT05895786
Sex: All
Age: 18+
Locations: 50
View study
Recruiting
MagnetisMM-32: A Study to Learn About the Study Medicine Called Elranatamab in People With Multiple Myeloma (MM) That Has Come Back After Taking Other Treatments (Including Prior Treatment With an Anti-CD38 Antibody and Lenalidomide)
  • Recruiting
NCT06152575
Sex: All
Age: 18+
Locations: 75
View study
...